High Altitude Acclimatization — MCQs

10 questions

Which of the following is a common genetic mutation leading to hypoxia-induced polycythemia in patients with chronic mountain sickness?

Which is a feature of high-altitude pulmonary edema?

During acclimatization to high altitude, all of the following take place except:

Which physiological adaptation does not happen at high altitudes?

Which of the following is seen in high altitude climbers?

What is the primary effect of acetazolamide at high altitudes?

If an anesthetist at high altitude uses plenum vaporizers, what will be the delivered vapor concentration?

What is the primary physiological effect of positive G forces on the human body?

At what altitude is kala azar unlikely to occur?

Q10

A hyperventilating patient has the following ABG values: pH=7.53, pCO2=20 mmHg, HCO3= 26 mEq/L. What is the most likely diagnosis?

High Altitude Acclimatization Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following is a common genetic mutation leading to hypoxia-induced polycythemia in patients with chronic mountain sickness?

A. EGFR gene mutation
B. JAK2 V617F mutation
C. HIF1α gene mutation
D. VHL gene mutation (Correct Answer)

Explanation: ***VHL gene mutation*** - **Von Hippel-Lindau (VHL) gene mutations** are associated with **Chuvash polycythemia**, a form of **primary familial congenital polycythemia (PFCP)**, which mimics chronic mountain sickness at normoxia by causing overproduction of red blood cells due to impaired **HIF-1α degradation**. - The VHL protein is a component of the **ubiquitin ligase complex** that targets **HIF-1α** for degradation under normoxic conditions. Dysfunction of VHL leads to constitutive activation of HIF-1α, over-expression of **erythropoietin (EPO)**, and subsequent **polycythemia** even at normal oxygen levels. *EGFR gene mutation* - **EGFR mutations** are commonly found in non-small cell lung cancer and are associated with tumor growth and response to targeted therapies, but they are not directly involved in the pathogenesis of **polycythemia** or its response to hypoxia. - These mutations primarily affect **cell proliferation and survival** pathways in cancerous cells, rather than erythropoiesis. *JAK2 V617F mutation* - The **JAK2 V617F mutation** is a hallmark of **myeloproliferative neoplasms (MPNs)**, particularly **polycythemia vera (PV)**, leading to constitutive activation of the JAK-STAT pathway and uncontrolled erythropoiesis independent of erythropoietin. - While it causes **polycythemia**, this is typically considered a primary, acquired bone marrow disorder, not directly linked to the hypoxia-sensing pathway dysregulation seen in **chronic mountain sickness**. *HIF1α gene mutation* - While **HIF-1α** is central to the hypoxic response, direct activating mutations in the **HIF1α gene** itself are generally not the most common genetic cause of **hypoxia-induced polycythemia** in humans. - The dysregulation typically occurs upstream, often through mutations in the **VHL gene**, which controls HIF-1α stability.

Question 2: Which is a feature of high-altitude pulmonary edema?

A. Associated with low cardiac output
B. Exercise has no effect
C. Associated with pulmonary hypertension (Correct Answer)
D. Occurs in both acclimatized and unacclimatized persons

Explanation: ***Associated with pulmonary hypertension*** - **High-altitude pulmonary edema (HAPE)** is characterized by **exaggerated hypoxic pulmonary vasoconstriction**, leading to significantly increased pulmonary artery pressures. - This **pulmonary hypertension** drives fluid extravasation into the alveolar spaces, causing non-cardiogenic pulmonary edema. *Associated with low cardiac output* - HAPE is typically associated with **normal or elevated cardiac output** in response to hypoxia, not low cardiac output. - Low cardiac output suggests conditions like cardiogenic shock or severe myocardial dysfunction, which are not primary features of HAPE. *Exercise has no effect* - **Physical exertion at altitude** is a significant risk factor and can worsen HAPE due to increased cardiac output and pulmonary blood flow, exacerbating pulmonary hypertension. - Rest and reduced activity are crucial components of preventing and treating HAPE, indicating that exercise does indeed have an effect. *Occurs in both acclimatized and unacclimatized persons* - HAPE primarily affects **unacclimatized individuals** or those who ascend rapidly to high altitudes. - While rare, it can occur in previously acclimatized individuals returning to altitude after a period at lower elevations or in those with predisposing factors, but it is predominantly a disease of the unacclimatized.

Question 3: During acclimatization to high altitude, all of the following take place except:

A. Increase in minute ventilation
B. Increase in the sensitivity of carotid body to hypoxia
C. Shift in the oxygen dissociation curve to the left (Correct Answer)
D. Increase in 2,3-BPG levels in red blood cells

Explanation: ***Shift in the oxygen dissociation curve to the left*** - Acclimatization to high altitude involves a **right shift** in the oxygen dissociation curve, not a left shift. This right shift, facilitated by an increase in 2,3-bisphosphoglycerate (2,3-BPG), allows for **improved oxygen unloading** to tissues at lower partial pressures of oxygen. - A left shift would mean that hemoglobin has a **higher affinity for oxygen**, hindering its release to the tissues, which would be detrimental in a low oxygen environment. - Note: Acute exposure causes a temporary left shift due to respiratory alkalosis, but chronic acclimatization produces a right shift. *Increase in minute ventilation* - A primary response to high altitude is an **increase in minute ventilation** (the total volume of air inhaled or exhaled per minute). - This increased breathing rate and depth helps to counteract the **lower partial pressure of oxygen** in the atmosphere, thereby maintaining alveolar oxygen levels. *Increase in the sensitivity of carotid body to hypoxia* - During acclimatization, the **carotid body's sensitivity to hypoxia** increases, leading to a stronger ventilatory response to low oxygen levels. - This enhanced sensitivity helps in maintaining adequate oxygenation by **stimulating increased breathing**. *Increase in 2,3-BPG levels in red blood cells* - Acclimatization leads to increased production of **2,3-bisphosphoglycerate (2,3-BPG)** in red blood cells. - This facilitates the **right shift of the oxygen dissociation curve**, promoting oxygen release to tissues at high altitude where oxygen partial pressure is low.

Question 4: Which physiological adaptation does not happen at high altitudes?

A. Pulmonary vasoconstriction
B. Respiratory acidosis (Correct Answer)
C. Hypoxia
D. Polycythemia

Explanation: ***Respiratory acidosis*** - At high altitudes, the primary physiological response to **hypoxia** is to increase ventilation, leading to a decrease in **arterial PCO2**. - This reduction in **PCO2** causes **respiratory alkalosis**, not acidosis, as the body tries to compensate for the lower oxygen levels. *Pulmonary vasoconstriction* - This is a significant physiological response to **hypoxia** at high altitudes, leading to an increase in **pulmonary artery pressure**. - Its purpose is to divert blood flow to better-ventilated areas of the lung, but it can also contribute to **pulmonary hypertension**. *Hypoxia* - Reduced **atmospheric pressure** at high altitudes directly results in a lower partial pressure of oxygen (**PO2**), leading to **hypoxia**. - This low **PO2** is the primary trigger for most other physiological adaptations seen at high altitudes. *Polycythemia* - Prolonged exposure to **hypoxia** stimulates the kidneys to release **erythropoietin (EPO)**, which in turn increases **red blood cell production**. - This adaptive increase in **red blood cell count** and **hemoglobin concentration** aims to enhance the oxygen-carrying capacity of the blood.

Question 5: Which of the following is seen in high altitude climbers?

A. Hyperventilation
B. Pulmonary edema
C. Decreased PaCO2
D. All of the options (Correct Answer)

Explanation: ***All of the options*** - High altitude climbers experience **hypoxia**, which triggers several physiological responses as the body tries to compensate. - **Hyperventilation**, **pulmonary edema**, and **decreased PaCO2** are all common occurrences in individuals exposed to high altitudes. *Hyperventilation* - **Hypoxia** at high altitudes stimulates the peripheral chemoreceptors, leading to an increased respiratory rate and depth. - This increased ventilation is a compensatory mechanism to try and increase **oxygen intake**. *Pulmonary edema* - **High-altitude pulmonary edema (HAPE)** is a potentially life-threatening condition caused by exaggerated hypoxic pulmonary vasoconstriction. - This leads to increased pulmonary arterial pressure, capillary leakage, and **fluid accumulation in the lungs**. *Decreased PaCO2* - The increased respiratory rate due to **hyperventilation** causes an excessive exhalation of carbon dioxide. - This results in a **decreased partial pressure of arterial carbon dioxide (PaCO2)**, leading to respiratory alkalosis.

Question 6: What is the primary effect of acetazolamide at high altitudes?

A. Increase CO2
B. Decrease ventilation
C. Elevate pH
D. Reduce HCO3- (Correct Answer)

Explanation: ***Reduce HCO3-*** - Acetazolamide is a **carbonic anhydrase inhibitor**, which primarily acts in the renal tubules to prevent the reabsorption of bicarbonate (HCO3-). - This leads to a loss of bicarbonate in the urine, causing **metabolic acidosis**, which in turn stimulates ventilation and counteracts the effects of high altitude. *Increase CO2* - Acetazolamide's action to induce metabolic acidosis through bicarbonate excretion actually **stimulates ventilation**, leading to a *decrease* in CO2, not an increase. - An increase in CO2 would further depress respiration and worsen high-altitude symptoms. *Decrease ventilation* - The primary goal of acetazolamide at high altitude is to *increase* ventilation by inducing metabolic acidosis, which then stimulates peripheral chemoreceptors. - A decrease in ventilation would exacerbate **hypoxia** and symptoms of acute mountain sickness. *Elevate pH* - By promoting the excretion of bicarbonate (a base), acetazolamide effectively *lowers* the blood pH, creating a state of **metabolic acidosis**. - An elevated pH (alkalosis) would suppress the respiratory drive, which is counterproductive at high altitudes.

Question 7: If an anesthetist at high altitude uses plenum vaporizers, what will be the delivered vapor concentration?

A. Lower than concentration at same partial pressure
B. Higher than the concentration at same partial pressure (Correct Answer)
C. Lower than the concentration at lower partial pressure
D. Higher than the original concentration at high partial pressure

Explanation: ***Higher than the concentration at same partial pressure*** - Plenum vaporizers are calibrated at **sea level** and deliver a constant *volume percent* of volatile anesthetic. At high altitude, ambient pressure is lower, meaning a given volume percent represents a **higher partial pressure** of anesthetic. - While the *anesthetic partial pressure* might be what the anesthetist aims for, the *delivered concentration* (volume percent) will be higher than the concentration that would achieve the same partial pressure at sea level because the total pressure is lower. *Lower than concentration at same partial pressure* - This statement is incorrect because a plenum vaporizer will deliver a **higher partial pressure** at altitude for a given dial setting, due to the reduced ambient pressure. - A lower partial pressure for the same set concentration would only occur if the ambient pressure were higher than calibration. *Lower than the concentration at lower partial pressure* - This option is vaguely worded and does not accurately describe the behavior of plenum vaporizers at altitude. When total pressure drops, the *partial pressure* delivered by a plenum vaporizer at a given dial setting will increase, not decrease. - A lower vapor concentration leading to a lower partial pressure is generally true, but it doesn't address the specific issue of a plenum vaporizer's performance at high altitude. *Higher than the original concentration at high partial pressure* - This option is confusing as it refers to "original concentration at high partial pressure" which isn't a standard comparison. The key is that a plenum vaporizer's *delivered volume % remains constant*, regardless of altitude. - However, this constant volume % translates to a higher *partial pressure* when the **ambient atmospheric pressure is lower**, as is the case at high altitude.

Question 8: What is the primary physiological effect of positive G forces on the human body?

A. Increased cardiac output
B. Red out
C. Increased cerebral arterial pressure
D. Black out (Correct Answer)

Explanation: ***Black out*** - Positive G forces cause blood to pool in the **lower extremities**, leading to reduced blood flow to the brain and eyes, resulting in a **temporary loss of vision (blackout)**. - This is a direct consequence of the body's inability to maintain **cerebral perfusion** against the increased gravitational load. *Increased cardiac output* - While the heart may initially try to compensate, prolonged or high positive G forces can actually **decrease cardiac output** due to reduced venous return. - The primary hemodynamic effect is a redistribution of blood, not an overall increase in output. *Red out* - **Red out** (or red vision) is primarily associated with **negative G forces**, where blood surges towards the head. - It results from increased pressure in the cranial vessels, leading to capillary rupture and blood pooling in the eyes. *Increased cerebral arterial pressure* - Positive G forces cause a **decrease** in cerebral arterial pressure due to the displacement of blood away from the head. - A decrease in cerebral arterial pressure is the direct cause of the **vision impairment** and potential loss of consciousness.

Question 9: At what altitude is kala azar unlikely to occur?

A. 400 meters
B. 500 meters
C. 600 meters (Correct Answer)
D. 200 meters

Explanation: ***600 meters*** - Kala-azar, or **visceral leishmaniasis**, is primarily found in **low-lying areas** and is rarely reported at altitudes above 600 meters due to the specific ecological requirements of its **sand fly vector**. - The **Phlebotomus argentipes sand fly**, the main vector in the Indian subcontinent, prefers warm, humid climates and **lower altitudes**. *400 meters* - This altitude is within the **typical endemic range** for kala-azar, especially in regions like the Indian subcontinent. - The environmental conditions at 400 meters are generally conducive for the **survival and breeding** of the sand fly vector. *500 meters* - Similar to 400 meters, 500 meters is still considered within the **favorable altitude range** for kala-azar transmission. - The **sand fly vector** can thrive in the climate often found at this elevation. *200 meters* - This altitude represents a **highly endemic zone** for kala-azar, as it provides optimal conditions for the sand fly vector. - Lower altitudes are typically associated with increased **humidity and warmth**, favoring vector density and parasite transmission.

Question 10: A hyperventilating patient has the following ABG values: pH=7.53, pCO2=20 mmHg, HCO3= 26 mEq/L. What is the most likely diagnosis?

A. Metabolic alkalosis
B. Metabolic acidosis
C. Respiratory alkalosis (Correct Answer)
D. Respiratory acidosis

Explanation: ***Respiratory alkalosis*** - The pH of 7.53 indicates **alkalemia**, and the low pCO2 (20 mmHg) is the primary driver, signifying **respiratory alkalosis** - A hyperventilating patient exhales more CO2, leading to a decrease in its partial pressure in the blood and a subsequent rise in pH - The HCO3 is within normal range (26 mEq/L), indicating **uncompensated respiratory alkalosis** *Metabolic alkalosis* - This would be characterized by a high pH and an elevated **HCO3**, but the HCO3 is within the normal range (26 mEq/L) - While it causes alkalemia, the primary disturbance here is respiratory, not metabolic *Metabolic acidosis* - This would present with a **low pH** and a low **HCO3**, which is contrary to the given ABG values - The patient's pH is elevated, indicating an alkalotic state, not acidotic *Respiratory acidosis* - This would be defined by a **low pH** and an elevated **pCO2**, which is the exact opposite of the provided ABG results - The patient's high pH and low pCO2 rule out respiratory acidosis

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free